Advertisement
Advertisement
CERS
Cerus Corp
2.61
USDSponsored
0.00
0.00%
May 08, 15:59 UTC -4
Closed
Pre-Market
2.61
0.00
0.00%
CERS Earnings Reports
Positive Surprise Ratio
CERS beat 25 of 42 last estimates.
60%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$64.19M
/-$0.03
Implied change from Q1 26 (Revenue/ EPS)
+19.63%
/+200.00%
Implied change from Q2 25 (Revenue/ EPS)
+22.40%
/--
Cerus Corp earnings per share and revenue
On Apr 30, 2026, CERS reported earnings of -0.01 USD per share (EPS) for Q1 26, beating the estimate of -0.04 USD, resulting in a 75.49% surprise. Revenue reached 53.66 million, compared to an expected 54.23 million, with a -1.05% difference. The market reacted with a +33.99% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.03 USD, with revenue projected to reach 64.19 million USD, implying an increase of 200.00% EPS, and increase of 19.63% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
FAQ
What were Cerus Corp's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Cerus Corp reported EPS of -$0.01, beating estimates by 75.49%, and revenue of $53.66M, -1.05% below expectations.
How did the market react to Cerus Corp's Q1 2026 earnings?
The stock price moved up 33.99%, changed from $2.03 before the earnings release to $2.72 the day after.
When is Cerus Corp expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Cerus Corp's next earnings report?
Based on 5
analysts, Cerus Corp is expected to report EPS of -$0.03 and revenue of $64.19M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement